- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06664515
Changes InMPOD After Full-thickness Macular Hole Closure
Changes in Macular Pigment Optical Density After Full-thickness Macular Hole Closure Using Inverted Flap Technique
Study Overview
Detailed Description
Full-thickness macular hole (FTMH) is a debilitating retinal disorder, particularly in its advanced forms, necessitating surgical intervention for vision restoration. This study showes the successful closure of a large FTMH using the inverted flap technique, highlighting the essential role of multimodal imaging, and particularly of macular pigment optical density (MPOD) assessment, in preoperative and postoperative evaluation.
Surgery was performed by an expert vitreoretinal surgeon, resulting in significant postoperative improvements in visual acuity and retinal architecture. Multimodal imaging, including MPOD assessment, played a pivotal role in preoperative evaluation and postoperative monitoring.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Naples, Italy, 80100
- University of Naples "Federico II"
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:age older than 60 years
- diagnosis of FTHM
- absence of other ocular diseases, responsible for macular edema (retinal vein occlusion, diabetic retinopathy, age-related macular degeneration
Exclusion Criteria:
No diagnosis of pseudophakic cystoid macular oedema
- previous treatment for pseudophakic cystoid macular oedema
- presence of other ocular diseases, responsible for macular edema (retinal vein occlusion, diabetic retinopathy, age-related macular degeneration)
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Patients affected by macular hole
|
invert flap tecnique
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
MPOD After Full-thickness Macular Hole Closure (FTMH)
Time Frame: 6 months
|
The parameters analyzed by OCT and MPOD six months after surgery are: OCT MPOD visual acuity |
6 months
|
|
MPOD and Macula hole: before and after surgery
Time Frame: six months
|
The parameters analyzed six months after surgery are: MPOD Visual acuity OCT |
six months
|
Collaborators and Investigators
Sponsor
Investigators
- Study Chair: Ciro Costagliola, FEDERICOII UNIVERSITY
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 05809853 Federico II
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Full Macular Hole
-
The Filatov Institute of Eye Diseases and Tissue...Ukrainian Vitreoretinal SocietyEnrolling by invitationMacular Holes | Idiopathic Macular Hole | Macular Hole | Full Thickness Macular HoleUkraine
-
Rigshospitalet, DenmarkRecruiting
-
Vienna Institute for Research in Ocular SurgeryCompleted
-
University of Turin, ItalyUnknownFull Thickness Macular HoleItaly
-
Moorfields Eye Hospital NHS Foundation TrustCompletedFull Thickness Macular HoleUnited Kingdom
-
NHS Greater Glasgow and ClydeCompletedFull Thickness Macular HoleUnited Kingdom
-
University of AberdeenNHS Grampian; Chief Scientist Office of the Scottish GovernmentCompletedStage 2 or 3 Full Thickness Macular HoleUnited Kingdom, Ireland
-
Allen C. Ho, MDMid Atlantic RetinaCompletedRetinal Detachment | Epiretinal Membrane | Full Thickness Macular HoleUnited States
-
Jaeb Center for Health ResearchNational Eye Institute (NEI); National Institutes of Health (NIH)CompletedVitreomacular Traction (VMT) | Full-thickness Macular Holes (MH)United States
-
Prim. Prof. Dr. Oliver Findl, MBAActive, not recruitingRetinal Detachment | Full Thickness Macular Hole | Epiretinal MembranesAustria
Clinical Trials on Ciro Costagliola
-
San Salvatore Hospital of L'AquilaCompletedNeuropathic Pain | Somatic PainItaly